HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data
Provided By PR Newswire
Last update: Apr 16, 2025
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, has licensed its real-world data to enhance clinical trial design and analytics.
Read more at prnewswire.com
